TGFBR2 and metastatic malignant neoplasm in the lymph nodes: Several authors, have associated the TGFBR2-875G>A polymorphism with a decreased risk for gastric cancer, esophageal squamous cell carcinoma, breast cancer, and lymph node metastasis, especially in the Asian population [28–33].